Blood Pressure Targets in Hypertension
Introduction to Blood Pressure Management
- The World Health Organization recommends a blood pressure target of <140/90 mmHg for all patients with hypertension without comorbidities (strong recommendation) 1
- The European Society of Cardiology guidelines recommend targeting systolic blood pressure to 120-129 mmHg in most adults to reduce cardiovascular risk, provided treatment is well tolerated 2, 3
Risk Stratification and Targeting Strategy
- The American Diabetes Association recommends targeting blood pressure <130/80 mmHg for diabetic patients (strong recommendation) 4, 8
- Patients with established cardiovascular disease should target systolic blood pressure <130 mmHg (strong recommendation) 1
- High cardiovascular risk patients (diabetes, chronic kidney disease, 10-year ASCVD risk ≥15%) should target systolic blood pressure <130 mmHg (conditional recommendation) 1
Special Populations
- Elderly patients ≥65 years should target systolic blood pressure 130-139 mmHg 2, 3, 9
- Patients ≥85 years should consider more lenient targets (e.g., <140 mmHg) 2, 3
- Frail patients at any age should consider targets <140/90 mmHg 2, 3
Evidence from Major Trials
- The SPRINT trial found that intensive treatment (target <120 mmHg) reduced major cardiovascular events by 25% compared to standard treatment (target <140 mmHg) 4, 5, 8
- The ACCORD BP trial found that intensive treatment (target <120 mmHg) did not significantly reduce the primary composite cardiovascular endpoint in diabetic patients, but reduced stroke risk by 41% 4, 5, 8
Safety Considerations
- Diastolic blood pressure <60 mmHg is associated with increased cardiovascular events in patients with treated systolic blood pressure <130 mmHg 1
- Treatment should be de-intensified if blood pressure falls to <90/60 mmHg 5
- Optimal diastolic blood pressure appears to be 70-79 mmHg when systolic blood pressure is at target 2, 3
Common Adverse Events
- Hypotension and syncope are common adverse events with intensive treatment 4, 5, 8
- Electrolyte abnormalities (hyperkalemia) and acute kidney injury are also common adverse events with intensive treatment 4, 5, 8
- Falls (particularly in elderly patients) and orthostatic symptoms are additional concerns with intensive treatment 7, 2, 3